Freeslate Customer Forum Highlights Best Practices in High Throughput Research and Data Management

Share Article

Mind-sharing Among Industry Leaders Included Case-Studies, Hands-on Training, New Product Demos, and Networking

News Image
With the Forum, we are pleased to provide a platform that brings together the best ideas to help scientists learn, explore, and achieve their R&D goals.

Freeslate, Inc., the leading provider of high throughput research solutions for biopharmaceutical development, today announced highlights of its annual customer meeting, “Freeslate Forum 2015”, held April 28 – 30, 2015 at the Hyatt Fisherman’s Wharf in San Francisco. The meeting featured in-depth hands-on training, opportunities to explore the latest advancements in Freeslate solutions, and discussions of best practices in high throughput research and data management for R&D directors, managers, and scientists from the pharmaceutical and chemical fields.

At this year’s Customer Forum, approximately 45 people gathered to discuss the challenges and opportunities of high throughput chemistry research and bring knowledge about best practices back to their organizations. The Forum consisted of formal, case-study presentations by a diverse set of customers including GlaxoSmithKline, Caltech, Argonne National Laboratory, Amgen, Pfizer, and Lawrence Berkeley National Laboratory, who highlighted their experience with Freeslate tools to achieve dramatic innovation and rapid return on investment. Hands-on training sessions were given by Freeslate staff, focused on accelerating productivity. Delegates also toured Freeslate’s headquarters where they were treated to new product demonstrations of the Optimization Sampling Reactor (OSR) and the Buffer Exchange System and joined strategic product discussions designed to influence the next round of product development at Freeslate. Further, networking between sessions and at evening events offered attendees opportunities for one-on-one discussions and sharing best practices.

“We recognize the unique challenges facing scientists today who are under pressure to accelerate innovation with less resources than they have ever had before,” said John S. Senaldi, President and CEO of Freeslate. “With the Forum, we are pleased to provide a platform that brings together the best ideas to help scientists learn, explore, and achieve their R&D goals.”

A fantastic keynote presentation given by Svend Ludvigsen, Vice President of Diabetes Formulation, Biophysics, & Structure at Novo Nordisk A/S, titled “Increasing the success rate of therapeutic development by assessing the developability of proteins during discovery” discussed how to effectively use automation systems and informatics to accelerate drug development in modern pharmaceutical organizations.

At this year’s Freeslate Customer Forum, attendees said the conference was “a great venue to understand how many companies have integrated automation into their lab workflows. It was great to obtain candid opinions on initial implementation and development of the workflows.” Another mentioned that “people participated and were truly interested in what other researchers have been doing with their Freeslate instruments and the people I interacted with are open in discussing their problems along with sharing their solutions. Overall, I enjoyed the forum and have learned in greater detail of what Freeslate can offer to departments that would like to automate. I will relay what I have gathered at this meaningful forum to my group when I head back to work.” A majority of this year’s attendees plan to attend next year.

Additional information about Forum 2015 can be found by visiting

About Freeslate

Freeslate is a privately held company providing laboratory automation products that dramatically improve the productivity and innovation of drug development organizations. For more than a decade, Freeslate has been working with customers to automate complex chemical research processes. Our resulting product line includes solutions for protein and vaccine drug formulation development, small molecule solubility, and polymorph screening and process chemistry. We start with a scientific understanding of our customer’s bottlenecks and utilize our robust and proprietary automation platforms and integrated Lab Execution and Analysis (LEA) software suite to deliver solutions that make a difference. The company is headquartered in Sunnyvale, California, with direct sales and service in North America, Europe, and Asia. For more information, visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mikelle Thatcher
Freeslate, Inc.
+1 (408) 773-4081
Email >
Visit website